|Articles|July 15, 2002

BioPharm International

  • BioPharm International-07-01-2002
  • Volume 15
  • Issue 7

Inside Washington: One Hundred Years of Biotech Regulation

Author(s)Jill Wechsler

by Jill Wechsler, CBER is heralding its rich regulatory history while preparing to tackle new scientific and administrative challenges.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 23 years ago

Facilitating Client Audits: The Contract Laboratory Perspective

over 23 years ago

Outsourcing Outlook: Optimizing Cross-Organizational Team Performance and Management

over 23 years ago

Analytical Advances: When an Industry Requires Multiterabyte Data Protection

over 23 years ago

Validation of Large-Scale Chromatographic Processes, Part 2: Results from the Case Study of Neuleze Capture on Macroprep High-S

over 23 years ago

Knowledge Management: The Four Pillars of Success

over 23 years ago

Guest Editorial: Supreme Court Rules on Festo

over 23 years ago

Optimizing Recombinant Microbial Fermentation Processes: An Integrated Approach

over 23 years ago

Virus Inactivation in the 1990's ? and into the 21st Century. Part 1: Skin, Bone, and Cells

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!